Raynaud Phenomenon: Clinical Trials

2 trials for Raynaud Phenomenon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1

Follow Raynaud Phenomenon: new trials by email Literature Review of Raynaud Phenomenon trials Research Report on Raynaud Phenomenon

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Botulinum Toxin in Raynaud's Phenomenon
Botulinum toxin - Raynaud Phenomenon
Phase 4CompletedEmory University242022-02-102026-07-29
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
AbobotulinumtoxinA, Saline solution - Raynaud Phenomenon
Phase 4TerminatedUniversity of Central Florida32018-08-312021-06-30

Narrower conditions

Raynaud Disease (2)

Broader conditions

Cardiovascular Diseases (2)  ·  Embolism and Thrombosis (2)  ·  Livedoid Vasculopathy (2)  ·  Peripheral Vascular Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Vascular (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Thrombosis (2)  ·  Vascular Diseases (2)

Interventions

Botulinum Toxins (1)  ·  Saline Solution (1)  ·  abobotulinumtoxinA (1)

Sponsors

Emory University (1)  ·  University of Central Florida (1)

Countries

United States (2)

Top investigators

Paul A Ghareeb, MD (1)